Create a free account to follow companies and stay updated on team changes
bluebird bio
About
bluebird bio is developing innovative gene therapies for severe genetic diseases and cancer. Our vision is to make the hope of gene therapy a reality.
- Website
- Headquarters
- Industry
- Social
Team
View all (22)
Nick Leschly
CEO
Derek Adams
Chief Technology and Manufacturing Officer
Alison Conlon
VP, Portfolio & Program Management
Alison Finger
Chief Commercial Officer
Andreas Kouri
VP, Global Supply Chain
Andrew Obenshain
Head of Europe
Chip Baird
Chief Financial Officer
David Davidson
Chief Medical Officer
Gary Fortin
Vice President & Franchise Head for Severe Genetic Diseases
Jason F. Cole
Chief Operating & Legal Officer
Joanne Smith-Farrell
Senior Vice President, Corporate Development and Strategy
Kathy Wilkinson
Chief People Officer
Announcements
View all (0)Jobs
View all (0)Similar companies
Genentech82 positions
Verve Therapeutics29 positions
Aridis Pharmaceutical12 positions
Qualigen Therapeutics11 positions
Surface Oncology28 positions
Biogen27 positions
Alexion Pharmaceuticals21 positions
Theravance22 positions
AVM Biotech21 positions
DNAnexus13 positions
Myriad Genetics23 positions
Kura Oncology29 positions
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.